Ángel Lucio
Ángel Lucio serves as the CEO of Tetraneuron, a biotech company focused on developing a groundbreaking gene therapy for Alzheimer's disease. With a keen understanding of the challenges posed by the high costs and complexities of gene therapies, Lucio is dedicated to navigating the path from research to clinical application. He aims to ensure that their innovative treatment can reach patients suffering from moderate to severe Alzheimer's, ultimately striving to provide hope for those affected by this devastating condition.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Ángel Lucio is the CEO of Tetraneuron and is aware of the challenges ahead to reach patients with their gene therapy.
6